Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT06172127
PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer
165 Enrollment(s)
36 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Breast Cancer
RECRUITING
NCT06610825
Castrate Resistant Prostate Cancer Enhertu Therapy
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Prostate Cancer Metastatic


Prostate Cancer


CRPC
RECRUITING
NCT05633979
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
37 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Breast Cancer
TERMINATED
NCT05744375
Trastuzumab Deruxtecan in First-line HER2-positive Locally Advanced/MBC Patients Resistant to Trastuzumab+Pertuzumab
2 Enrollment(s)
19 Study location(s)
INTERVENTIONAL (PHASE2)
Locally Advanced Breast Cancer


Metastatic Breast Cancer
RECRUITING
NCT07073755
Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd
200 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Metastatic Breast Cancer


Drug Resistance


Hormone Receptor-Positive Breast Cancer


HER2-positive Breast Cancer


Triple-Negative Breast Cancer (TNBC)


Treatment Decisions
RECRUITING
NCT07065435
RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study
74 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2 + Breast Cancer
ACTIVE_NOT_RECRUITING
NCT05650879
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
198 Enrollment(s)
39 Study location(s)
INTERVENTIONAL (PHASE1)
HER2 Mutant Non-small Cell Lung Cancer


HER2-positive Metastatic Breast Cancer


HER2 Gene Mutation


HER2 Amplification
ACTIVE_NOT_RECRUITING
NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
1,200 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Acute Ischemic Stroke


Atrial Fibrillation


Extracranial Atherosclerosis


Intracranial Atherosclerosis


Coronary Artery Atherosclerosis


Peripheral Artery Stenosis


Anticoagulant


Antiplatelet